Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERAP2 | Q6P179 | 6/20 | 0.46 |
| ▸ | ERAP1 | Q9NZ08 | 6/20 | 0.46 |
| ▸ | LNPEP | Q9UIQ6 | 5/20 | 0.46 |
| ▸ | NPY1R | P25929 | 3/20 | 0.46 |
| ▸ | NPY2R | P49146 | 3/20 | 0.46 |
| ▸ | NPY4R | P50391 | 3/20 | 0.46 |
| ▸ | GHSR | Q92847 | 4/20 | 0.46 |
| ▸ | UTS2R | Q9UKP6 | 1/20 | 0.45 |
| ▸ | IL1RN | P18510 | 2/20 | 0.44 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.43 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.43 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.43 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.43 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.43 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.43 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.43 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.43 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.43 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.43 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12515258 | 0.95 | ERAP2 (0.47) | ERAP2ERAP1LNPEPNPY1RNPY2R | |
| SCHEMBL21371598 | 0.95 | ERAP2 (0.47) | ERAP2ERAP1LNPEPNPY1RNPY2R | |
| SCHEMBL19219805 | 0.95 | ERAP2 (0.47) | ERAP2ERAP1LNPEPNPY1RNPY2R | |
| SCHEMBL12515009 | 0.93 | GHSR (0.47) | ERAP2ERAP1LNPEPGHSRUTS2R | |
| SCHEMBL17949851 | 0.91 | UTS2R (0.43) | GHSRUTS2RHDAC8HDAC3HDAC4 | |
| SCHEMBL19445785 | 0.90 | ERAP1 (0.57) | ERAP2ERAP1LNPEPIL1RN | |
| SCHEMBL10262224 | 0.90 | ERAP1 (0.57) | ERAP2ERAP1LNPEPIL1RN | |
| SCHEMBL19945114 | 0.89 | ERAP1 (0.57) | ERAP2ERAP1LNPEPIL1RN | |
| SCHEMBL21371584 | 0.89 | ERAP1 (0.57) | ERAP2ERAP1LNPEPIL1RN | |
| SCHEMBL10262860 | 0.88 | SUV39H2 (0.48) | ERAP2ERAP1LNPEPGHSRHDAC8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160213668-A1 | Compounds for use in Treatment of Mucostis | INNOVATION PHARMACEUTICALS INC. | 2016-07-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160213668-A1 | Compounds for use in Treatment of Mucostis | MUC1, SOST, ALG1 | ERAP2 1201/4885ERAP1 2517/4885LNPEP 2208/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.